The 7 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 70.00, with a high estimate of 95.00 and a low estimate of 65.00. The median estimate represents a +57.27% increase from the last price of 44.51.
The current consensus among 7 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.60
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.